Table 2.
Knowledge of and compliance with guideline recommendations.
| No. | Recommendations | N (%) | p-value | |
|---|---|---|---|---|
| Knowledge | Compliance | |||
| 1 | The presence of detrusor muscle in the specimen is necessary for the NMIBC patients having had initial TURBT | 786 (97.40) | / | / |
| 2 | Perform a single postoperative instillation of intravesical chemotherapy after TURBT | 780 (96.77) | / | / |
| Further chemotherapy instillations | ||||
| 3 | Not recommended for low-risk NMIBC patients | 32 (3.97) | 13 (1.61) | <0.001 |
| 4 | Provide induction and maintenance chemotherapy instillations for intermediate-risk NMIBC patients | 735 (91.99) | 743 (92.99) | 0.243 |
| 5 | Provide induction and maintenance chemotherapy instillations for high-risk NMIBC patients | / | 704 (89.00) | / |
| BCG immunotherapy | ||||
| 6 | Not recommended for low-risk NMIBC patients | 336 (43.08) | 307 (39.36) | 0.181 |
| 7 | Provide induction and maintenance chemotherapy instillations for intermediate-risk NMIBC patients | 513 (66.97) | 518 (67.62) | 0.685 |
| 8 | Provide induction and maintenance chemotherapy instillations for high-risk NMIBC patients | 608 (79.89) | 614 (80.68) | 0.451 |
| 9 | Indications for a second TURBT | |||
| After incomplete initial TURBT | 640 (79.60) | 542 (67.41) | <0.001 | |
| There is no muscular layer in the first resected specimen (except for TaLG/G1 tumor and carcinoma in situ) | 598 (74.38) | 595 (74.00) | 0.863 | |
| In T1 tumors | 347 (43.16) | 357 (44.40) | 0.474 | |
| In G3/high-grade tumors (except for CIS) | 456 (56.72) | 441 (54.85) | 0.228 | |
| Pathology analysis results of initial TURBT failed to determine stage or risk grading | 485 (60.32) | 443 (55.10) | 0.001 | |
| 10 | Indications for radical cystectomy | |||
| High-grade T1 with histological variation (micropapillary, sarcoma, small cell type) | 466 (58.54) | 398 (50.00) | <0.001 | |
| High-grade T1 with lymphatic vessel infiltration, multiple and/or large high-grade T1, high-grade T1 with bladder/prostate CIS | 654 (82.16) | 634 (79.65) | 0.111 | |
| Pathology analysis results of a second TURBT is still high-grade T1 | 491 (61.68) | 545 (68.47) | <0.001 | |
| High-grade NMIBC with early recurrence within 3 months | 532 (66.83) | 542 (68.09) | 0.440 | |
| NMIBC involving the bladder diverticulum | 331 (41.58) | 384 (48.24) | <0.001 | |
| High-risk NMIBC patients with BCG failure | 590 (74.12) | 526 (66.08) | <0.001 | |